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Abstract
Purpose To evaluate the efficacy of ultrasonography-guided percutaneous treatment of de Quervain tenosynovitis with the 
combination of a corticosteroid injection and release of the retinaculum of the first extensor compartment tendons 
with a 21-gauge needle.
Materials and methods The first part of our study consisted of ten procedures on cadaver wrists followed by dissection to analyse 
the effectiveness of the retinaculum release and detect any collateral damage. The second part was a prospective clinical study of 
35 procedures. Outcomes were evaluated through a 6-month clinical follow-up and telephone interview at the end of the study. 
The following parameters were monitored over time: pain level on a visual analogue scale, the QuickDASH and the PRWE. 
Patient satisfaction questionnaires were also administered.
Results No complications were found during the cadaver study. However, the release was confirmed as ‘partial’ in all wrists. In 
the clinical portion of this study, significant improvement was observed in 91.4 % of cases (32/35) within 1 month and the results 
were stable until the end of the study; all of these patients avoided surgery. The release procedure failed in three patients who 
eventually required surgical treatment.
Conclusion US-guided partial release and simultaneous corticosteroid injection for treatment of de Quervain’s disease
using a 21-gauge needle is feasible in current practice, with minimal complications.
Key Points
• Ultrasound guided treatment of de Quervain's disease is feasible with a 21G needle.
• There was notable regression of clinical signs in 91.4 % of cases.
• The procedure is very safe, no iatrogenic neurovascular or tendinous injuries occurred.
• Our procedure requires only one session and 3 days away from work.
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Abbreviations
APL Abductor Pollicis Longus
EPB Extensor Pollicis Brevis
PRWE Patient Rated Wrist Evaluation
Quick DASH Quick Disabilities of the Arm,
Shoulder and Hand outcome measure
RNSB Radial nerve’s sensory branch
VAS pain Visual analogue scale for pain
Introduction
De Quervain's disease [1] is a specific form of stenosing teno-
synovitis in the wrist due to a mismatch between the size of
the tendons of the first extensor compartment (abductor
pollicis longus (APL) and extensor pollicis brevis (EPB))
and the size of the osteofibrous tunnel in which they are lo-
cated. This tenosynovitis manifests itself as pain on the radial
side of the wrist, which is increased by performing the
Finkelstein test [2]. This is a common disease, with 1.2%
prevalence [3]. It mostly affects women (prevalence of 1.3–
2.8 %) [4, 5]) particularly some new mothers who develop
‘baby wrist’ [6]. Men are, however, not immune to this con-
dition (0.6 %[3, 5]), particularly manual laborers who perform
repetitive movements [3].
Ultrasonography (US) is an excellent modality for ex-
ploring this condition, as it provides an accurate assess-
ment of the local damage and anatomical variations [7,
8]. Hypoechogenic thickening of the retinaculum is present
and measures 2.01 mm on average [8]. It can encompass
both tendons without a septum (type 1 according to Volpe
et al.) [8] or only the EPB with a septum (type 2) [8]. The
presence of this intertendinous septum, which is easily
seen with US [9], contributes to the occurrence of de
Quervain's tenosynovitis and increases friction on the
EPB [10]. Its frequency varies from 29 % to 81 % of cases,
depending on the study [8, 9, 11–13]. US can also detect a
hyperintense Doppler signal in the retinaculum [8] and
anatomical tendon variations (multi-fasciculated APL [9],
bifid or absent EPB [9, 14]).
The initial medical care varies between teams but typi-
cally consists of stopping pain-inducing movements, brac-
ing [15], NSAIDs and corticosteroid injections. If conser-
vative treatment fails, surgical treatment (release of radial
styloid pulley) can be proposed to the patient [16]. Various
types of reconstruction procedures have been described
[17–21] to prevent the most typical complication – anterior
tendon dislocation [22].
Up to now, the therapeutic role of US was limited to deter-
mining the exact location for corticosteroid injection to
achieve optimal diffusion within the EPB tendon sheath [23]
or around both tendons [24], thereby reducing the probability
of failure [25, 26]. Very few studies apply US-guided
percutaneous release in the case of de Quervain’s tenosynovi-
tis [11, 27]. The purpose of our study was to evaluate the
effectiveness of US-guided release using a 21-gauge (G; 0.8-
mm) needle in this pathology, based on our experience with
treating trigger finger using this technique [28].
Materials and methods
Our two-part study was approved by our Research Ethics
Committee. It consisted of cadaver and clinical experiments
conducted jointly by a hand surgeon (12 years’ experience)
and an interventional radiologist specializing in musculoskel-
etal procedures (17 years’ experience).
Cadaver study
A feasibility study was performed in cadavers to confirm that
the retinaculum of the first compartment of extensor tendons
could be cut using a 21-G needle. This release is feasible, but
requires ten back-and-forth movements of the needle to be
complete (Fig. 1). Based on these findings, the radiologist
performed an US-guided release of the retinaculum of the first
compartment in ten wrists of five fresh cadavers (four women
and one man, mean age 82 years). Subsequently, the surgeon
carefully dissected the treated wrists to analyse the condition
of the retinaculum, tendons and adjacent neural and vascular
structures.
Fig. 1 Transection with a 21 G needle of the retinaculum of the first
extensor compartment in a cadaver specimen. Tendons of the first
extensor compartment and their retinaculum are exposed after
dissection of overlying tissues on the radial side of the wrist of a fresh
cadaver (89 year old female). A 21 G needle is slid longitudinally over
the retinaculum using the needle's bevel as a surgical knife. After ten or so
back and forth passes, the retinaculum is transected (arrows), revealing
the extensor pollicis brevis (E) and abductor pollicis longus (A) tendons.
Clinical study
Study population
Over a 2-year period starting in January 2015, 38 patients
were included in our prospective study. The inclusion criteria
were presence of de Quervain's tenosynovitis for at least 4
months (mean 5.7 months, range 4–12 months) that was re-
calcitrant to conservative treatment, and a positive Finkelstein
test. Patients were excluded if they had previously undergone
surgery in the first extensor compartment, had another hand
pathology, or were lost to follow-up.
During the consultation before the procedure, the surgeon
proposed the US-guided release procedure to 38 patients and
obtained written informed consent from each one. Three pa-
tients were excluded during the study: two were lost to follow-
up and one developed symptoms of carpal tunnel syndrome.
Hence, data from 35 patients (sevenmen, 28 women) between
22 and 74 years of age (average 54 years) were available for
analysis. Among the 35 treated wrists, 13 were left wrists and
22 were right wrists.
Release procedure
All the procedures were performed by the radiologist using an
US unit (model Aplio 400; Toshiba Medical Systems, Tokyo,
Japan) with a high-frequency transducer (14–18 MHz). The
patient was positioned supine on a stretcher; the hand was set
on its medial side on a table with slight ulnar deviation (see
Online Supplemental Material, Fig. 1). A sterile working area
was prepared.
First, a scan of the entire region was done with the US
probe to locate the radial nerve’s sensory branch (RNSB)
and its divisions. Then local anaesthetic was injected with a
25-mm long, 25-G needle (orange hub) (see Online
Supplemental Material, Fig. 1). The needle's entry point was
about 1 cm distal and lateral to the styloid process of the
radius; the needle was oriented on the coronal plane towards
the distal end of the retinaculum. Two cc of 1% lidocaine HCl
(Xylocaine; AstraZeneca, Rueil-Malmaison, France) was
injected along the needle’s path and into the synovial sheath
of the first compartment extensor tendons (Fig. 2; Online
Supplemental Material, Movie 1).
Next, the base of a 50-mm long, 21-G needle (green hub)
was manually curved to a 140° angle so that its bevel faced
laterally (Figs. 3 and 4). This curvature had two effects: it
placed the needle in a completely horizontal position and
made it possible to determine the bevel’s orientation, even
when it was hidden beneath the patient’s skin.
The 21-G needle used the same trajectory as the anaes-
thetic injection with US guidance; its exact positioning was
adjusted according to the type of De Quervain's tenosyno-
vitis (Fig. 5). Once the optimal position had been
confirmed in the longitudinal and transverse planes (Fig.
6; see Online Supplemental Material, Fig. 2), the radiolo-
gist slid the needle horizontally over the retinaculum
(Movie 1 [Online Supplemental Material]) making about
ten back-and-forth passes, while always keeping the
needle’s tip in sight to reduce the possibility of damaging
Fig. 2 Ultrasonography is used to guide the local anaesthesia over the
path of the retinaculum of the first extensor compartment being released.
On this longitudinal view of the radial side of the wrist, the dotted line
indicates the needle's theoretical path. Care is needed to avoid the small
superficial vein (V') located in the path. The needle's path must reach the
deep and distal portion of the thickened retinaculum (arrows) and position
itself superficial to the extensor pollicis brevis tendon (E). The anisotropic
area in the tendon (**) at the distal portion of the first compartment
extensor is evidence of the sudden change in direction of the tendon
fibres where the most stenosis exists. The anaesthetic agent will be
injected along the needle's path and in the sheath of the first extensor
compartment tendons. This injection may be difficult and generally
only involves the distal recess of the tendon sheaths (blue oval shape).
Deep to the tendons, the radial artery (A) and satellite veins (V) are visible
at the anatomical snuffbox. R = radial styloid
Fig. 3 Photograph of a US guided release for de Quervain's tenosynovitis
(simulation). The ulnar side of the hand rests on a small bolster made of a
sterile drape which places the wrist in slight ulnar deviation; this makes it
easier to approach the radial side of the first compartment without
interference from the thumb column. The procedure is carried out in
sterile conditions: sterile drapes (removed for the purpose of this
photo), skin disinfection, use of sterile gel and sterile probe cover,
sterile gloves. A pad of sterile gel (**) is placed between the probe and
the patient's skin; this allows the operator to accurately locate the needle's
path before it breaches the patient's skin
neighbouring structures. In doing so, an experienced radi-
ologist feels a slight resistance consistent with a transected
fibrous structure. To release an intertendinous septum ef-
fectively, a 90° rotation of the needle was required to orient
the bevel perpendicular to the fibres being cut (see Online
Supplemental Material, Fig. 3).
When the radiologist felt a significant reduction in the
retinaculum's resistance upon sliding the needle, 0.5 cc
xylocaine was injected through the 21-G needle left in
place (Movie 1 [Online Supplemental Material]). The fluid
then easily diffuses in the EPB and APL sheath proximal
and distal to the retinaculum. Next, 0.5 cc (or 3.5 mg)
betamethasone (MSD, Courbevoie, France) was injected
inside the tendon sheath.
Assessment of clinical outcomes
On the day of the procedure (D0), before starting, the radiol-
ogist performed a clinical examination with a Finkelstein test
and asked the patients to rate their highest pain level in the
prior 7 days (visual analogue scale (VAS) pain, 0–10) and
their function using two questionnaires: Quick DASH
(Quick Disabilities of the Arm, Shoulder and Hand outcome
measure) and PRWE (Patient Rated Wrist Evaluation). US
was also performed to analyse the location and thickness of
the retinaculum, presence of a thickened intertendinous sep-
tum and presence of a hyperintense signal in Doppler mode.
Fig. 5 Various types of de Quervain's tenosynovitis were found in our
cohort, which had to be targeted differently in the release procedure. Here,
the three types have drawings of an axial slice of the wrist and the
corresponding ultrasonography images. Type 1 consists of overall
thickening (arrows on US image, thick red line on drawing) of the
retinaculum surrounding the extensor pollicis brevis (E) and abductor
pollicis longus (A). The ‘X’ marks the ideal area for partial transection
of the retinaculum at its zenith, close of the surface of the underlying
tendons. In Type 2a, there is overall thickening of the retinaculum
(arrows on US image, thick red line on drawing) and a thickened
septum is present (arrow head on US image, red line on drawing).
Release (XX) will occur in the common retinaculum where it joins with
the septum and if possible, in the septum itself. In Type 2b, the
retinaculum around the extensor pollicis brevis is thickened (arrows on
US image, thick red line on drawing) and a thickened septum is present
(arrow head on US image, red line on drawing). The theoretical areas for
partial release are marked with ‘XX’.
Fig. 4 Drawing of the position of the 21 G needle used in release of de
Quervain's tenosynovitis. This is a dorsal viewwith the wrist resting on its
ulnar side. The tendons of the first extensor compartment are surrounded
by their retinaculum (light green), which has semicircular fibres (curved
red lines) perpendicular to the long axis of the tendons. The 21 G needle
enters the retinaculum on its distal side with the bevel angled laterally
(close up of needle in dotted circle). In this way, the bevel is
perpendicular to the long axis of its fibres and is better able to transect
them. A translation movement along the path of the retinaculum's apex
will be applied to the needle. A = APL; E = EPB; R1 = extensor carpi
radialis longus; R2= extensor carpi radialis brevis
This US assessment was used to classify patients into one
of three categories:
– Type 1: overall thickening of retinaculum in first com-
partment, without intertendinous septum
– Type 2a: overall thickening of retinaculum in first com-
partment and presence of thickened intertendinous
septum
– Type 2b: EPL retinaculum is thickened in combination
with a thickened intertendinous septum; the retinaculum
around the APL has a normal appearance.
US was also used to evaluate the appearance of the RNSB,
EPB and APL before and after the release procedure to detect
any complications.
One month (M1) and 6 months (M6) after the procedure,
the patients were seen again by the surgeon who then per-
formed a new clinical examination and evaluated the highest
pain level in the prior 7 days (VAS), QuickDASH and PRWE.
Between these two planned visits, patients had the option to
call the surgeon if the disease symptoms worsened.
Patients were contacted by telephone at the end of the
study, an average of 12.1 months after the procedure (SD 7
months, range 6–24months]), by a radiology resident to again
determine the VAS pain level, QuickDASH, PRWE and eval-
uate the patient's satisfaction with their care: very satisfied,
satisfied, somewhat satisfied, not satisfied.
Statistical analysis
The following tests were used in the statistical analysis:
– McNemar’s test to evaluate changes in the Finkelstein test
– Paired Student's t-test for changes over time in the VAS
pain, Quick DASH and PRWE assessments
– Logistic regression to look for relationships between
variables.
Results
Cadaver study
The following observations were made after dissecting the ten
cadaver wrists that underwent US-guided release:
– every retinaculum is thin (average thickness of 0.5 mm)
and has no intertendinous septum;
– the retinaculum was not completely released in all cases.
Instead the result is partial thickness cuts over a portion of
the retinaculum’s length (Online Supplemental Material,
Fig. 4);
– there were no dislocations or tendon damage of the ex-
tensors in the first compartment;
– no damage to the sensory branches of the radial nerve
occurred;
– no vascular damage occurred.
Clinical study
Status of patients on D0
The clinical characteristics of these patients were somewhat
heterogeneous (Table 1). The patients did not receive exactly
the same conservative treatment initially. The patients were
typically referred to the study’ surgeon once non-operative
treatments had failed (Table 2).
US performed on D0 found the retinaculum was thickened
in every patient (mean 1.9 mm; SD 0.4 mm). Doppler mode
revealed a hyperintense signal in the retinaculum and tendon
sheath in 71.4 % of cases (n=25/35). The breakdown of de
Quervain's types in the study cohort was: 42.9 % Type 1
(n=15/35), 20 % Type 2a (n=7/35) and 37.1 % Type 2b
(n=13/35). Thus, 57.1 % of patients (20/35) had an
intertendinous septum.
Fig. 6 Example of a release being performed in the left wrist of a 57 year
old female patient with type 1 de Quervain's tenosynovitis. (a)
Longitudinal view of the radial side of the wrist showing the thickened
retinaculum over the tendons of the first extensor compartment (arrows)
and the 21 G needle (arrow with dotted line) on the retinaculum's path
superficial to the extensor pollicis brevis. (b) Transverse axial view in the
small axis of the tendons of the first compartment (E extensor pollicis
brevis,A abductor pollicis longus): here, the needle is a hyperechogenic
spot (arrow with dotted line) deep to the apex of the thickened
retinaculum (arrows).
After the release procedure, US showed no damage to the
RNSB, no complete transection of the retinaculum, and all the
more, no tendon dislocation.
Outcomes
At the 1-month follow-up with the surgeon, the Finkelstein
test was negative in 91.4 % of cases (n = 32/35), which was a
highly significant improvement (p < 0.001). The 32 patients
who had a negative Finkelstein test at 1 month had a clear
improvement 7 days after the procedure on average (SD =
6.3). The three other patients (all of whom were subsequently
operated on) felt they had improved after 1 week, but their
pain reappeared in 2–3 weeks.
The VAS for pain, Quick DASH and PRWE all improved
significantly within the first month (Table 3) (p < 0.001).
At 6 months and at the end of the study, these outcomes
were maintained, as there were no differences relative to the 1-
month outcomes (0.5 < p < 0.9).
When asked if they were satisfied with the outcome of the
procedure:
- 77.1 % (27/35) of patients were satisfied or very satisfied;
among these 27 patients, seven had previously undergone one
or two unsuccessful corticosteroid injections;
– 14.3 % (5/35) of patients were somewhat satisfied; three
of these five patients had some improvement but had
persistent background pain and did not want further treat-
ment; the two other patients mentioned having significant
pain for 3 days after the procedure.
– 8.6 % (3/35) of patients were not satisfied and subse-
quently underwent surgery: 4 months after the procedure
for two patients and 1 year for one patient. The appear-
ance found during surgery was the same as the one found
during the initial US examination: thickened septum and
retinaculum (mean 1.9 mm) around the EPB in two cases
(type 2b) and both tendons in one case (type 2a). There
was no visible evidence of the US-guided percutaneous
release.
Among the three patients who underwent secondary sur-
gery, two of them were on sick leave for work. The surgical
procedure was successful in two cases. In the third case, pain
persisted and made it impossible for this patient to return to
work.
The logistic regression analysis found no statistically sig-
nificant relationship between patient satisfaction or need for
surgical treatment and:
– retinaculum thickness
– type of de Quervain's disease (1, 2a or 2b)
– hyperintense signal in Doppler mode.
Conversely, a patient being on sick leave from work was a
predictor of poor prognosis. The risk of undergoing surgery
was increased 14 times (odds ratio (OR) = 14; p < 0.05).
Complications and costs
The average procedure time was 15 min (SD = 1.4); once the
local anaesthesia was in place, the procedure was painless.
Table 1 Clinical features of the
35 patients in our study cohort Feature Number of patients (%)
Manual labour (iron worker, waiter, nurse's aide, aerospace engineer) n=11/35 (31.4 %)
Retired n=11/35 (31.4 %)
Manual hobby (gardening, do it yourself) n=8/35 (23 %)
Household chores (cooking, cleaning) n=6/35 (17 %)
Women caring for newborns (3 mothers, 2 grandmothers) n=5/35 (14 %)
Sports involving upper limb (weight training, rugby, gold, petanque) n=4/35 (11.4 %)
Patient who received aromatase inhibitor for breast related condition n=1/35 (3 %)
Table 2 Types of conservative
(non operative) treatment
performed in the study patients
Type of treatment used before the release procedure Number of patients (%)
Wrist splint n=35/35 (100 %)
NSAIDs (per os, topical) n=35/35 (100 %)
Relative rest (alteration of job duties, stoppage of recreational activities) n=32/35 (91 %)
Physical therapy with different modalities n=9/35 (26 %)
Work stoppage (average of 3 months) n=7/35 (20 %)
1 or 2 standard percutaneous corticosteroid injections n=7/35 (20 %)
Acupuncture n=1/35 (3 %)
Subcutaneous bruising appeared the day after the procedure in
two patients (6 %) and had resolved after 1 week. The primary
complaint after the procedure was an increase in pain on the
evening of the procedure in six patients (17 % of cases) which
lasted an average of 3.3 days (SD = 2).
These minor incidents led us to adopt the following course
of action after the procedure: application of a compressive
dressing, recommendation to wear a brace and to take analge-
sics in case of pain, and 3 days off work. No other clinical
complications were observed:
– no tendon dislocation during dynamic movements
– no elective pain in the radial nerve's sensory territory
– no skin atrophy at the needle entry point.
The cost of this US-guided release procedure is less than
the cost of standard surgery for de Quervain's disease (Online
Supplementary Material, Table 1). Standard surgical care in-
volves a visit with the surgeon, ultrasonography, nerve block
by an anaesthesiologist, surgical release, 3 weeks away from
work and nursing care at home for the wound. The US-guided
release procedure involves a diagnostic US examination, US-
guided release with corticosteroid injection, and 3 days away
from work. Nursing care at home was not required since there
was no wound.
Discussion
Overview of study
The purpose of our study was to evaluate the effectiveness
of simultaneous corticosteroid injection and partial US-
guided release using a 21-G (0.8-mm) needle in patients
with de Quervain's tenosynovitis. In our study, 91.4 % of
patients (32/35) avoided surgery and were able to resume
their activities with significantly less pain within 1 month.
Among these patients, five were only ‘somewhat satisfied’
with the outcome: two because of pain in the days imme-
diately after the procedure and three because of residual
pain (less than initial pain levels), probably due to an in-
sufficient partial release. Our procedure was effective, fast
and low-cost. The 0.8-mm needle entry point means that
nursing care at home is unnecessary and it allows patients
to return to work after 3 days.
None of the typical complications of corticosteroid injec-
tion or surgery were observed. The context of sick leave from
work was the only risk factor identified for a poor outcome
(OR = 14). The presence of an intertendinous septum was not
associated with treatment failure in our study.
Our good outcomes may appear contradictory to the results
of our cadaver study in which only partial release was accom-
plished. In our clinical study after the release procedure, US
showed no complete transection of the retinaculum. During
surgery in the three operated patients there was no visible
evidence of the US-guided percutaneous release, likely due
to an incomplete release associated with well-organized scar
tissue.
However, we can presume that partial release of the APL
and EPB compartments with simultaneous corticosteroid in-
jection might be sufficient to eliminate a patient’s symptoms.
Comparison with other studies and techniques
US-guided percutaneous release with a needle has been per-
formed successfully with another common type of stenosing
tenosynovitis: trigger finger with A1 pulley transection
[28–31]. In the context of trigger finger [28], the same tech-
nique induced partial anatomical release that was clinically
effective. To our knowledge, there are few studies on percu-
taneous release of the first extensor tendon compartment with
a needle. Guleç et al. [11] described a feasibility study in 48
cadaver wrists with an 18-G needle but no US guidance.
Complete release was achieved in only 52.1 % of cases (25/
48). Several complications occurred in the tendons, including
a 39.6 % (19/48) laceration rate. The absence of tendon-
related complications in our study can likely be attributed to
the US-guided nature of our procedure. In a 2013 case report
[27], Peck described good clinical outcomes after performing
tenotomy with an 18G needle and injecting platelet-rich
plasma.
In the literature, simple corticosteroid injections are often
described as being effective for de Quervain's disease. The
most optimistic studies report a success rate between 82.5 %
(52/63) [26] and 90 % (47/52) [32]. However, upon closer
scrutiny of these studies, the first corticosteroid injection is
Table 3 Change in the VAS for pain, QuickDASH and PRWE after release of the retinaculum of the first extensor compartment. All three outcome
measures improved significantly (p < 0.001) 1 month after the procedure. At 6 months and the end of the study, the improvement is still present but did
not change significantly, suggesting the initial improvement at 1 month is stable for at least 6 months (mean follow up of 12.1 months)
D0 M1 M6 End of study
VAS pain mean (standard deviation) 7,2 (1.9) 1 (1.8) 0,8 (1.3) 0,8 (1.3)
QuickDASH mean (standard deviation) 64,6 (17,1) 11,2 (21) 5,9 (11) 5,2 (10,2)
PRWE mean (standard deviation) 69,4 (15,5) 11,9 (22) 7,9 (13,4) 6,8 (13,4)
effective in only 58 % (30/52) [32] to 71 % of cases (45/63)
[26].Multiple injections are required to attain the reported 80–
90 % success rate; however, the tradeoff is skin-related com-
plications: cutaneous atrophy and melting of hypodermic fat
in 31 % of cases (16/52) in the study by Anderson et al. [32].
The presence of an intertendinous septum is typically a risk
factor for failure of this injection, as it limits diffusion of the
injected product [25, 33]. This was not the case in our study.
After the release in every patient, homogeneous diffusion of
xylocaine and then cortisone in the sheath of both tendons was
achieved, thereby optimizing the injection and limiting the
subcutaneous diffusion of corticosteroids.
The historical gold standard treatment – surgery – is now
reserved for failures of conservative treatment [32]. Its success
rate ranges from 81 % to 100 % [20, 32]. However, surgical
treatment implies a relatively long time away from work (3
weeks) and can result in various complications, such as volar
dislocation of extensor tendons in the first compartment [22],
wound dehiscence [34] and damage to the radial nerve's sen-
sory branches [34]. None of these complications occurred in
our study.
Kazmers et al. [35] showed that certain psychosocial fac-
tors were associated with a higher rate of surgical treatment. In
our study, ‘being on sick leave’was identified as a predictor of
poor outcomes, as it was associated with more frequent surgi-
cal treatment (OR = 14).
Limitations
Our study has limitations. The primary one is that a single
radiologist performed all the release procedures. The
operator-dependent nature of US-guided release was not
evaluated.
Perspectives
Conclusion
US-guided release of the retinaculum of the first extensor
compartment in the context of de Quervain's disease is feasi-
ble with a 21-G (0.8-mm) needle. This procedure is fast, not
very painful, low risk and low cost. Return to work is possible
after 3 days, even in manual laborers. The outcome is satis-
factory in 77.1 % of cases, and 91.4 % of patients avoided
surgical treatment. The effectiveness of this partial anatomical
release is potentiated by concurrent injection of corticoste-
roids. The patients' symptoms and function improve within 1
month and are stable for at least 6 months.
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